Lv3
350 积分 2023-04-13 加入
Differential survival outcomes of satisfactory tumor response (ypStage I) following neoadjuvant chemoradiotherapy vs. neoadjuvant immunochemotherapy of esophageal squamous cell cancer
29天前
已完结
Neoadjuvant chemoradiation with camrelizumab and nimotuzumab for initially inoperable esophageal squamous cell carcinoma: A single-arm phase 2 trial
3个月前
已完结
Risk of isolated nodal failure for non-small cell lung cancer (NSCLC) treated with the elective nodal irradiation (ENI) using 3D-conformal radiotherapy (3D-CRT) techniques – A retrospective analysis
3个月前
已完结
Elective Nodal Irradiation (ENI) Doesn't Appear to Provide a Clear Benefit for Patients With Unresectable Non–Small-Cell Lung Cancer (NSCLC)
3个月前
已完结
Elective Nodal Irradiation (ENI) in Locally Advanced Non–Small-Cell Lung Cancer (NSCLC): Evidence Versus Opinion?
3个月前
已完结
Elective Nodal Irradiation (ENI) Does Not Appear to Provide a Clear Benefit for Patients With Unresectable Non–Small-Cell Lung Cancer (NSCLC): In Regard to Schild et al. (Int J Radiat Oncol Biol Phys 2008;72:335–342)
3个月前
已完结
Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes
3个月前
已完结
Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non–Small-Cell Lung Cancer
3个月前
已完结
Induction chemotherapy plus camrelizumab followed by concurrent chemoradiotherapy in unresectable locally advanced esophageal squamous cell carcinoma: a single-arm phase II trial
5个月前
已完结
Comparative efficacy of immunotherapy-based treatment versus chemotherapy-only in patients with unresectable NSCLC with disease progression post chemoradiation and durvalumab
5个月前
已关闭
皖公网安备34019202002308
